The Pharmaceutical Market: New Zealand - Market Research Reports

Printer Friendly

Printed from http://www.researchandmarkets.com/reports/45274

The Pharmaceutical Market: New Zealand

Description:

THE PHARMACEUTICAL MARKET: NEW ZEALAND - REVIEW

The macroenvironment for New Zealand’s pharmaceutical market is restricted by low GDP and population size. Economically, New Zealand will be the smallest economy in the Asia Pacific region covered by Espicom in 2016. In terms of GDP per capita, however, New Zealand has a high rate for the region. Legally, New Zealand is a member of the WTO, and as a developed country it abides by the TRIPS agreement. However, the USTR remains concerned about the policies and operation of New Zealand’s Pharmaceutical Management Agency (Pharmac). Demographically, the EIU projects that New Zealand will have the smallest population in the Asia Pacific region in 2016. The elderly population is expected to increase in the forecast period and will be the fourth highest rate in the Asia Pacific region. New Zealand is also restricted by the remoteness of its geographical location.

The Pharmaceutical Inspection Convention/Pharmaceutical Inspection Co-operation Scheme (PIC/S) Guidelines to Good Manufacturing Practice (GMP) PE 009-8, Parts I, II and Annexes 1 to 3, 6 to 15, 17, 19 and 20 have been adopted as the New Zealand Code of Good Manufacturing Practice for Manufacture and Distribution of Therapeutic Goods Part 1: Manufacture of Pharmaceutical Products. Therefore New Zealand adheres to the PIC/S guidelines on GMP and packaging for medicinal products. Pharmaceutical regulation is primarily the responsibility of New Zealand’s Medicines and Medical Devices Safety Authority (Medsafe). This authority regulates all products used for a therapeutic purpose, using the Medicines Act 1981 and Regulations 1984. Medsafe is the regulatory agency responsible for overseeing pharmacovigilance activities.

Espicom expects the pharmaceutical market in New Zealand to grow at a low single-digit CAGR in US dollar terms during the forecast period. It will be the fourth smallest pharmaceutical market in the Asia Pacific region covered by Espicom in 2016. Very little pharmaceutical manufacturing takes place in New Zealand, with only a handful of companies operating factories in the country and no multinational manufacturing presence. This is partly due to Pharmac’s, the government body responsible for pricing and reimbursement, strict policies that deter multinational companies from setting up operations. New Zealand is heavily dependent on the import of retail medicaments, which account for over three-quarters of the total imports.

ENHANCED STRATEGIC INTELLIGENCE

These highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:

- Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
- Specialised intelligence on OTCs, generics, biologics and biosimilars.
- Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
- A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.
- The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.

HEALTHCARE STATISTICS

A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included.

Contents:

HEALTHCARE STATISTICS

A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included.

EXECUTIVE SUMMARY
Including Espicom's at a glance strategic analysis and key data projections

MACROENVIRONMENT
Political, economic, legal and demographic analysis

EPIDEMIOLOGY
Disease burden and prevalence

HEALTHCARE
Organisation, expenditure, infrastructure, services and workforce

REGULATORY AFFAIRS
Regulatory developments and marketing registration/authorisation

PRICING & REIMBURSEMENT

DISTRIBUTION CHANNELS

MARKET ANALYSIS
Projections, product development, manufacturing and trade

COMPETITION
Trade associations, trade fairs, company intelligence and competitive strategies

OTC PHARMACEUTICALS

GENERIC PHARMACEUTICALS

BIOLOGICS & BIOSIMILARS

OPPORTUNITIES & CHALLENGES
Espicom's unique strategic analysis

DIRECTORY

METHODOLOGY & SOURCES

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/45274

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2
Printed 13/02/2012 08:05:13

Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.


Product Name:
The Pharmaceutical Market: New Zealand
Web Address:
http://www.researchandmarkets.com/reports/45274
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format	Quantity	Price
Electronic (Online Access) - Enterprisewide		€5,050.00
Electronic (PDF) - Enterprisewide		€5,050.00
Electronic (Online Access) - Single User		€775.00
Hard Copy		€775.00 + EUR€ 50.00 Shipping/Handling *
Electronic (PDF) - Single User		€775.00

* Shipping/Handling is only charged once per order.

Contact information
Please enter all the information below in BLOCK CAPITALS.


	First Name:	Last Name:
	Email Address:
	Job Title:
	Organisation:
	Address:
	City:
	Postal/Zip Code:
	Country:
	Phone Number:
	Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed 13/02/2012 08:05:13

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

	American Express
	Diners Club
	Master Card
	Visa


Cardholder's Name:

Cardholder's Signature:

Expiry Date:	/

Card Number:

CVV Security Code:

Issue Date:	/ (Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:


Account number:	83313083
Sort code:	98-53-30
Swift code:	ULSBIE2D
IBAN number:	IE78ULSB98533083313083
Bank Address:	Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland.

If you have a Marketing Code please enter it below:
	Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)